Home › Funds › Ally Bridge Group (NY) LLC › ANTX
Ally Bridge Group (NY) LLC position in ANTX
AN2 THERAPEUTICS INC · Health Care
Ally Bridge Group (NY) LLC reported holding 526,315 shares of ANTX (AN2 THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$2.5M, representing 2.25% of its reported portfolio and ranking #16 among its reported holdings. Ally Bridge Group (NY) LLC has disclosed ANTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Ally Bridge Group (NY) LLC's ANTX position evolved
Ally Bridge Group (NY) LLC first disclosed a stake in ANTX in Q1 2026 at 526,315 shares (US$1.8M). The position peaked in Q2 2026 at 526,315 shares, worth US$2.5M. Across 2 filings, Ally Bridge Group (NY) LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 526,315 shares valued at US$2.5M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 526.32K | $1.80M | New |
| Q2 2026 | 526.32K | $2.55M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ANTX and 13F data
ANTX (AN2 THERAPEUTICS INC) is a Health Care company. 45 other funds we track also report a position in ANTX — the largest reported positions include Vivo Capital, LLC (US$15.3M), Commodore Capital LP (US$14.2M), Spruce Street Capital LP (US$8.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANTX
- Vivo Capital, LLC 3.15M sh · $15.26M · Q2 2026
- Commodore Capital LP 2.93M sh · $14.20M · Q2 2026
- Spruce Street Capital LP 1.66M sh · $8.04M · Q2 2026
- Almitas Capital LLC 1.47M sh · $7.11M · Q2 2026
- Boxer Capital Management, LLC 749.03K sh · $3.63M · Q2 2026
- Stonepine Capital Management, LLC 551.69K sh · $2.67M · Q2 2026
- Sio Capital Management, LLC 529.93K sh · $2.56M · Q2 2026
- Prosight Management, LP 474.64K sh · $2.30M · Q2 2026
- Aldebaran Capital, LLC 367.44K sh · $1.78M · Q2 2026
- Velan Capital Investment Management LP 40.00K sh · $193.60K · Q2 2026
More on Ally Bridge Group (NY) LLC
FAQ
How long has Ally Bridge Group (NY) LLC held ANTX?
Ally Bridge Group (NY) LLC has disclosed ANTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Ally Bridge Group (NY) LLC's current position in ANTX?
As of Q2 2026, Ally Bridge Group (NY) LLC holds 526.32K shares of ANTX (AN2 THERAPEUTICS INC), valued at $2.55M, representing 2.25% of its reported portfolio and ranking #16.
Has Ally Bridge Group (NY) LLC been buying or selling ANTX?
In the latest 13F filing (Q2 2026), Ally Bridge Group (NY) LLC held unchanged its position in ANTX. The position peaked in Q2 2026 at 526.32K shares.
Which other funds hold ANTX?
Other major institutional holders of ANTX include Vivo Capital, LLC, Commodore Capital LP, Spruce Street Capital LP, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.